Eugenia Piliotis

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Rethinking how we educate our future physicians: the Queen's-Lakeridge Health Medical Degree Family Medicine program: an innovative approach to medical education.

Rethinking how we educate our future physicians: the Queen's-Lakeridge Health Medical Degree Family Medicine program: an innovative approach to medical education.

Journal: Canadian medical education journal

Published: July 12, 2026

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.

Journal: Leukemia & lymphoma

Published: October 11, 2018

Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study.

Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study.

Journal: Hematological oncology

Published: March 21, 2018

Autologous stem cell transplant and combination immunotherapy of rituximab and interferon-α induces prolonged clinical and molecular remissions in patients with follicular lymphoma.

Autologous stem cell transplant and combination immunotherapy of rituximab and interferon-α induces prolonged clinical and molecular remissions in patients with follicular lymphoma.

Journal: British journal of haematology

Published: January 31, 2018

Intravascular Large B Cell Lymphoma Presenting as Transient Erythema Nodosum-Like Lesions and Fever.

Intravascular Large B Cell Lymphoma Presenting as Transient Erythema Nodosum-Like Lesions and Fever.

Journal: The American journal of medicine

Published: August 14, 2016

Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study.

Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 27, 2015

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab.

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab.

Journal: Annals of hematology

Published: October 02, 2014

Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis.

Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis.

Journal: Leukemia & lymphoma

Published: January 24, 2014

Survival of patients with transformed lymphoma in the rituximab era.

Survival of patients with transformed lymphoma in the rituximab era.

Journal: Annals of hematology

Published: September 02, 2013

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.

Journal: British journal of haematology

Published: April 19, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026